AI to Support Mental Health Case Management Providers

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

280 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-19

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to assess the effectiveness of an artificial intelligence (AI) platform for case managers in a nonprofit health system specializing in mental health and substance use disorder. The main questions it aims to answer are:

1. Is the AI platform acceptable and feasible for case managers?
2. Does the AI platform improve providers' productivity and reported interventions? Participants will be approximately 30 case managers and their 250 adult clients receiving case management services. Researchers will compare the provider productivity and work satisfaction prior to the implementation of the AI platform to following its implementation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Optimizing Behavioral Healthcare Delivery Through Technology

NCT05745103

Mood Disorders Anxiety Disorders

COMPLETED NA

Chatbot for Depression, Anxiety, and Eating Disorders

NCT06013137

Depression Anxiety Eating Disorders

COMPLETED NA

IntelliCare: Artificial Intelligence in a Mobile Intervention for Depression and Anxiety (AIM)

NCT02176226

Major Depressive Disorder Anxiety Disorders

COMPLETED NA

Improving Primary Care in Patients With Mental Disorders

NCT00183313

Mental Disorders

COMPLETED PHASE3

IntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for Depression

NCT02801877

Depression Anxiety

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Depressive Disorder Anxiety Disorders Substance Use Disorders Post Traumatic Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

This study will follow a stepped-wedge, randomized controlled design, where each provider team will undergo two phases: SAU and the AI platform phase. All teams will initially start with SAU, and the AI platform will be sequentially introduced to teams over time. Teams will be randomly assigned to different time periods for the AI platform phase using simple randomization. The order of implementation will be determined by randomly selecting the number of the team from sealed envelopes every two months. In both phases, the study will enroll new and existing clients. At the end of the trial all teams would have used Eleos for a few months

Primary Study Purpose

OTHER

Blinding Strategy

NONE

The masking in this study involves a differential approach between providers and clients. Providers will be aware of whether they are in the Services-As-Usual (SAU) or Artificial Intelligence (AI) phase. However, participating clients will not be informed about the platform their provider is using to document their therapy sessions.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Services-as-usual (SAU)

During the services-as-usual (SAU) phase of this study, providers will deliver the routine case management services offered by Centerstone and report these services in the usual way they do.

Group Type NO_INTERVENTION

No interventions assigned to this group

Artificial Intelligence (AI)

Once randomized to start using the AI-based platform for documenting their services, providers will have access to the Eleos Health platform, a secure and HIPAA-compliant tool specifically designed for documenting behavioral health encounters. This AI-powered platform enables providers to complete progress notes more quickly. Providers will complete the progress notes on their phones, and these notes will be integrated into the client's electronic health records.

Group Type EXPERIMENTAL

Artificial Intelligence platform for case managers

Intervention Type OTHER

Providers will have access to the Eleos Health mobile AI platform to document their case management encounters.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Artificial Intelligence platform for case managers

Providers will have access to the Eleos Health mobile AI platform to document their case management encounters.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Participants must be adults.
2. Participants must be receiving case management services from a Centerstone provider

Exclusion Criteria

1. Participants currently involved in any other concurrent research study will be excluded to avoid potential confounding factors.
2. Participants with any medical conditions or medications that may significantly interfere with the study outcomes will be excluded.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes